Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NHLBI

A Device To Protect Coronary Arteries Against Compression During Transcatheter Mitral Valve Annuloplasty (PMVA)

  • Read more about A Device To Protect Coronary Arteries Against Compression During Transcatheter Mitral Valve Annuloplasty (PMVA)
US Application 60/932,611
Filed on 2007-05-31

Nitrite Adjunctive Therapy To Enhance Efficacy Of Reperfusion Therapy For Focal and Global Ischemia

  • Read more about Nitrite Adjunctive Therapy To Enhance Efficacy Of Reperfusion Therapy For Focal and Global Ischemia
US Application 60/911,026
Filed on 2007-04-10

Genetic Variation In The Estrogen Receptor, ESR1, Is Associated With Risk For Myocardial Infarction And Cardiovascular Evetns

  • Read more about Genetic Variation In The Estrogen Receptor, ESR1, Is Associated With Risk For Myocardial Infarction And Cardiovascular Evetns
US Application 60/517,425
Filed on 2003-11-04

Black-Blood steady-state magnetic resonance imaging

  • Read more about Black-Blood steady-state magnetic resonance imaging
US Application 60/745,197
Filed on 2006-04-20

A Device To Protect Coronary Arteries Against Compression During Transcatheter Mitral Valve Annuloplasty (PMVA)

  • Read more about A Device To Protect Coronary Arteries Against Compression During Transcatheter Mitral Valve Annuloplasty (PMVA)
US Application 60/858,716
Filed on 2006-11-14

TRIARYLMETHANE MATERIALS AND METHODS

  • Read more about TRIARYLMETHANE MATERIALS AND METHODS
US Application 60/835,069
Filed on 2006-08-03

Transformed Human CD36+ Cells Allow Productive Parvovirus B19 Infection

  • Read more about Transformed Human CD36+ Cells Allow Productive Parvovirus B19 Infection
US Application 60/808,904
Filed on 2006-05-26

Wide-area Fluorescence Detection System For Two-photon Microscopy

  • Read more about Wide-area Fluorescence Detection System For Two-photon Microscopy
US Application 60/835,462
Filed on 2006-08-04

GENOMICS OF IN-STENT RESTENOSIS

  • Read more about GENOMICS OF IN-STENT RESTENOSIS
US Application 60/798,019
Filed on 2006-05-04

The Use Of Transfected, Activated T Cells For The Expansion Of Antigen-specific CD4+ And CD8+ T Cells For Adoptive Immunotherapy

  • Read more about The Use Of Transfected, Activated T Cells For The Expansion Of Antigen-specific CD4+ And CD8+ T Cells For Adoptive Immunotherapy
US Application 60/804,404
Filed on 2006-06-09

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • Page 46
  • Page 47
  • Page 48
  • …
  • Next page ››
  • Last page Last »
Subscribe to NHLBI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health